Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
This study is currently recruiting participants.
Study NCT00178503 Information provided by National Institute of Mental Health (NIMH)
First Received: September 12, 2005 Last Updated: March 16, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Autism
Additional conditions recognized in this trial
Attention Deficit Disorder with Hyperactivity
Autistic Disorder
Disease
Hyperkinesis
More general conditions related to this trial
Attention Deficit and Disruptive Behavior Disorders
Child Development Disorders, Pervasive
Dyskinesias
Mental Disorders
Mental Disorders Diagnosed in Childhood
Nervous System Diseases
Neurologic Manifestations
Pathologic Processes
Signs and Symptoms
Interventions listed in this trial
Methylphenidate-extended release
Methylphenidate-instant release
Placebo
Additional drug interventions recognized in this trial
Methylphenidate
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Stimulants
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Mental Health (NIMH)
Back to top of Main Content
